Announcements Trials
Browse Landscape

Status

Completed 3

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 6Observational 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Breast Neoplasms 467Neoplasms 315Carcinoma, Non-Small-Cell Lung 269Prostatic Neoplasms 215Colorectal Neoplasms 207Lung Neoplasms 176Multiple Myeloma 123Melanoma 110Carcinoma, Renal Cell 107Ovarian Neoplasms 94Carcinoma, Hepatocellular 78Pancreatic Neoplasms 69Urinary Bladder Neoplasms 65Stomach Neoplasms 64Neoplasm Metastasis 64Leukemia, Lymphocytic, Chronic, B-Cell 62Colonic Neoplasms 59Leukemia, Myeloid, Acute 53Uterine Cervical Neoplasms 50Recurrence 49Liver Neoplasms 46Lymphoma, Follicular 45Lymphoma 45Leukemia, Myelogenous, Chronic, BCR-ABL Positive 39Esophageal Neoplasms 37Precursor Cell Lymphoblastic Leukemia-Lymphoma 36Lymphoma, Large B-Cell, Diffuse 35Hematologic Neoplasms 35Head and Neck Neoplasms 35Lymphoma, Non-Hodgkin 34

Interventions

radium Ra 223 dichloride 1enzalutamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Observational × Castration-resistant Prostate Cancer × Clear all
NCT02669771 2024-11-21

Long-Term Specified Drug Use-Results Survey for Xtandi Capsule

Astellas Pharma Inc

Completed
1,018 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT04232761 2024-07-17

RAPIT

Bayer

Completed
194 enrolled
Genitourinary

Castration-resistant Prostate Cancer

NCT04962880 2023-04-14

PROSPECT

AstraZeneca

Completed
388 enrolled
Genitourinary

Castration-resistant Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡